These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12865098)

  • 1. Radioimmunoassay of N-acetyl-N-formyl-5-methoxykynuramine (AFMK): a melatonin oxidative metabolite.
    Harthé C; Claudy D; Déchaud H; Vivien-Roels B; Pévet P; Claustrat B
    Life Sci; 2003 Aug; 73(12):1587-97. PubMed ID: 12865098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation of melatonin and its catabolites, N1-acetyl-N2 -formyl-5-methoxykynuramine and N1-acetyl-5-methoxykynuramine, by activated leukocytes.
    Silva SO; Rodrigues MR; Carvalho SR; Catalani LH; Campa A; Ximenes VF
    J Pineal Res; 2004 Oct; 37(3):171-5. PubMed ID: 15357661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N1-acetyl-N2-formyl-5-methoxykynuramine is a product of melatonin oxidation in rats.
    Rozov SV; Filatova EV; Orlov AA; Volkova AV; Zhloba AR; Blashko EL; Pozdeyev NV
    J Pineal Res; 2003 Nov; 35(4):245-50. PubMed ID: 14521629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized synthesis of the melatonin metabolite N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK).
    Ximenes VF
    J Pineal Res; 2008 Oct; 45(3):297-301. PubMed ID: 18373552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of N1-acetyl-N2-formyl-5-methoxykynuramine/N1-acetyl-5-methoxy-kynuramine formation from melatonin in mice.
    Niu S; Li F; Tan DX; Zhang L; Idle JR; Gonzalez FJ; Ma X
    J Pineal Res; 2010 Sep; 49(2):106-14. PubMed ID: 20545825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin.
    León J; Escames G; Rodríguez MI; López LC; Tapias V; Entrena A; Camacho E; Carrión MD; Gallo MA; Espinosa A; Tan DX; Reiter RJ; Acuña-Castroviejo D
    J Neurochem; 2006 Sep; 98(6):2023-33. PubMed ID: 16945113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin metabolite, N(1)-acetyl-N(1)-formyl-5-methoxykynuramine (AFMK), attenuates acute pancreatitis in the rat: in vivo and in vitro studies.
    Jaworek J; Szklarczyk J; Bonior J; Kot M; Goralska M; Pierzchalski P; Reiter RJ; Czech U; Tomaszewska R
    J Physiol Pharmacol; 2016 Jun; 67(3):411-21. PubMed ID: 27512002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of internal labeled standards of melatonin and its metabolite N1-acetyl-N2-formyl-5-methoxykynuramine for their quantification using an on-line liquid chromatography-electrospray tandem mass spectrometry system.
    Almeida EA; Klitzke CF; Martinez GR; Medeiros MH; Di Mascio P
    J Pineal Res; 2004 Jan; 36(1):64-71. PubMed ID: 14675132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The melatonin metabolite N1-acetyl-5-methoxykynuramine facilitates long-term object memory in young and aging mice.
    Iwashita H; Matsumoto Y; Maruyama Y; Watanabe K; Chiba A; Hattori A
    J Pineal Res; 2021 Jan; 70(1):e12703. PubMed ID: 33125735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel pathway for N1-acetyl-5-methoxykynuramine: UVB-induced liberation of carbon monoxide from precursor N1-acetyl-N2-formyl-5-methoxykynuramine.
    Seever K; Hardeland R
    J Pineal Res; 2008 May; 44(4):450-5. PubMed ID: 18194200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages.
    Mayo JC; Sainz RM; Tan DX; Hardeland R; Leon J; Rodriguez C; Reiter RJ
    J Neuroimmunol; 2005 Aug; 165(1-2):139-49. PubMed ID: 15975667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction.
    Ressmeyer AR; Mayo JC; Zelosko V; Sáinz RM; Tan DX; Poeggeler B; Antolín I; Zsizsik BK; Reiter RJ; Hardeland R
    Redox Rep; 2003; 8(4):205-13. PubMed ID: 14599344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High concentrations of the melatonin metabolite, N1-acetyl-N2-formyl-5-methoxykynuramine, in cerebrospinal fluid of patients with meningitis: a possible immunomodulatory mechanism.
    Silva SO; Ximenes VF; Livramento JA; Catalani LH; Campa A
    J Pineal Res; 2005 Oct; 39(3):302-6. PubMed ID: 16150112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin and its metabolite N(1)-acetyl-N(1)-formyl-5-methoxykynuramine improve learning and memory impairment related to Alzheimer's disease in rats.
    Rong K; Zheng H; Yang R; Liu X; Li L; Chen N; Zhao G; Gong C; Deng Y
    J Biochem Mol Toxicol; 2020 Feb; 34(2):e22430. PubMed ID: 31833155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice.
    Manda K; Ueno M; Anzai K
    J Pineal Res; 2007 Apr; 42(4):386-93. PubMed ID: 17439555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin and its metabolite N1-acetyl-N2-formyl-5-methoxykynuramine (afmk) enhance chemosensitivity to gemcitabine in pancreatic carcinoma cells (PANC-1).
    Leja-Szpak A; Nawrot-Porąbka K; Góralska M; Jastrzębska M; Link-Lenczowski P; Bonior J; Pierzchalski P; Jaworek J
    Pharmacol Rep; 2018 Dec; 70(6):1079-1088. PubMed ID: 30308458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils as a specific target for melatonin and kynuramines: effects on cytokine release.
    Silva SO; Rodrigues MR; Ximenes VF; Bueno-da-Silva AE; Amarante-Mendes GP; Campa A
    J Neuroimmunol; 2004 Nov; 156(1-2):146-52. PubMed ID: 15465605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK.
    Galano A; Tan DX; Reiter RJ
    J Pineal Res; 2013 Apr; 54(3):245-57. PubMed ID: 22998574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N1-acetyl-N2-formyl-5-methoxykynuramine modulates the cell cycle of malaria parasites.
    Budu A; Peres R; Bueno VB; Catalani LH; Garcia CR
    J Pineal Res; 2007 Apr; 42(3):261-6. PubMed ID: 17349024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The melatonin metabolite N-acetyl-5-methoxykynuramine is a potent singlet oxygen scavenger.
    Schaefer M; Hardeland R
    J Pineal Res; 2009 Jan; 46(1):49-52. PubMed ID: 18643875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.